BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34297301)

  • 21. ALKBH5-mediated m
    Hao L; Yin J; Yang H; Li C; Zhu L; Liu L; Zhong J
    Aging (Albany NY); 2021 Jan; 13(3):4045-4062. PubMed ID: 33428593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
    Qu S; Jin L; Huang H; Lin J; Gao W; Zeng Z
    BMC Cancer; 2021 Jun; 21(1):686. PubMed ID: 34112124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALKBH5 facilitates CYP1B1 mRNA degradation via m6A demethylation to alleviate MSC senescence and osteoarthritis progression.
    Ye G; Li J; Yu W; Xie Z; Zheng G; Liu W; Wang S; Cao Q; Lin J; Su Z; Li D; Che Y; Fan S; Wang P; Wu Y; Shen H
    Exp Mol Med; 2023 Aug; 55(8):1743-1756. PubMed ID: 37524872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. m
    Tang B; Yang Y; Kang M; Wang Y; Wang Y; Bi Y; He S; Shimamoto F
    Mol Cancer; 2020 Jan; 19(1):3. PubMed ID: 31906946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response.
    Yu F; Wei J; Cui X; Yu C; Ni W; Bungert J; Wu L; He C; Qian Z
    Nucleic Acids Res; 2021 Jun; 49(10):5779-5797. PubMed ID: 34048572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of m6A-factors METTL3, ALKBH5, and YTHDC1 alters HPV16 mRNA splicing.
    Cui X; Nilsson K; Kajitani N; Schwartz S
    Virus Genes; 2022 Apr; 58(2):98-112. PubMed ID: 35190939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. USP36 promotes tumorigenesis and drug sensitivity of glioblastoma by deubiquitinating and stabilizing ALKBH5.
    Chang G; Xie GS; Ma L; Li P; Li L; Richard HT
    Neuro Oncol; 2023 May; 25(5):841-853. PubMed ID: 36239338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rewiring of purine metabolism in response to acidosis stress in glioma stem cells.
    Xu X; Wang L; Zang Q; Li S; Li L; Wang Z; He J; Qiang B; Han W; Zhang R; Peng X; Abliz Z
    Cell Death Dis; 2021 Mar; 12(3):277. PubMed ID: 33723244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The RNA demethylase ALKBH5 promotes osteoblast differentiation by modulating Runx2 mRNA stability.
    Feng L; Fan Y; Zhou J; Li S; Zhang X
    FEBS Lett; 2021 Aug; 595(15):2007-2014. PubMed ID: 34105773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of ALKBH5 rejuvenates aged human mesenchymal stem cells and enhances their therapeutic efficacy in myocardial infarction.
    Gao X; Liang X; Liu B; Hong Y; He H; Shen Y; Chen J; Huang X; Hu B; Li W; Li X; Zhang Y
    FASEB J; 2023 Dec; 37(12):e23294. PubMed ID: 37966425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ALKBH5-mediated m6A modification of lncRNA KCNQ1OT1 triggers the development of LSCC via upregulation of HOXA9.
    Li Y; Yan B; Wang X; Li Q; Kan X; Wang J; Sun Y; Wang P; Tian L; Liu M
    J Cell Mol Med; 2022 Jan; 26(2):385-398. PubMed ID: 34850551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells.
    Luo J; Yu H; Yuan Z; Ye T; Hu B
    Clin Transl Oncol; 2023 Jul; 25(7):2265-2276. PubMed ID: 36820954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of ALKBH5 attenuates I/R-induced renal injury in male mice by promoting Ccl28 m6A modification and increasing Treg recruitment.
    Chen J; Xu C; Yang K; Gao R; Cao Y; Liang L; Chen S; Xu S; Rong R; Wang J; Zhu T
    Nat Commun; 2023 Mar; 14(1):1161. PubMed ID: 36859428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALKBH5-mediated m6A demethylation of lncRNA RMRP plays an oncogenic role in lung adenocarcinoma.
    Yu H; Zhang Z
    Mamm Genome; 2021 Jun; 32(3):195-203. PubMed ID: 33934179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased
    Luo Q; Gao Y; Zhang L; Rao J; Guo Y; Huang Z; Li J
    Biomed Res Int; 2020; 2020():5735279. PubMed ID: 32884942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ALKBH5-dependent m6A demethylation controls splicing and stability of long 3'-UTR mRNAs in male germ cells.
    Tang C; Klukovich R; Peng H; Wang Z; Yu T; Zhang Y; Zheng H; Klungland A; Yan W
    Proc Natl Acad Sci U S A; 2018 Jan; 115(2):E325-E333. PubMed ID: 29279410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation.
    He Y; Hu H; Wang Y; Yuan H; Lu Z; Wu P; Liu D; Tian L; Yin J; Jiang K; Miao Y
    Cell Physiol Biochem; 2018; 48(2):838-846. PubMed ID: 30032148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ALKBH5 regulates IGF1R expression to promote the Proliferation and Tumorigenicity of Endometrial Cancer.
    Pu X; Gu Z; Gu Z
    J Cancer; 2020; 11(19):5612-5622. PubMed ID: 32913456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. USF1-mediated ALKBH5 stabilizes FLII mRNA in an m6A-YTHDF2-dependent manner to repress glycolytic activity in prostate adenocarcinoma.
    Fu D; Si Q; Yu C; Han Z; Zang L
    Mol Carcinog; 2023 Nov; 62(11):1700-1716. PubMed ID: 37493109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. m
    Onalan E; Yakar B; Onalan EE; Karakulak K; Kaymaz T; Donder E
    J Coll Physicians Surg Pak; 2022 Sep; 32(9):1143-1148. PubMed ID: 36089710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.